Former Biogen R&D Chief Surfaces With Exosome-Focused Startup
This article was originally published in Scrip
Executive Summary
Douglas Williams turned heads in July when Biogen revealed that its executive vice president leading research and development was leaving to found a biotechnology startup, and now Williams has emerged from the fundraising process as the president and CEO of Codiak BioSciences with venture capital to develop exosomes-based therapeutics and diagnostics.